Home

Martine A. Rothblatt, Chairperson & CEO: United Therapeutics UTHR Sell · Filed 05/19

Trade details

Type
Insider sale
Amount
$1,293,786
Shares · price
2,280 sh · $567.45 a share
Held after
43,307 sh
Trade date
26/05/18
Filed
26/05/19
Days to filing
1 days

Sold 5.0% of holdings

Share of holding sold
5.0%

United Therapeutics trades, last 26 weeks

What else happened in United Therapeutics around then

Filed or reported within 30 days of the trade day · 04/18~06/17

Martine A. Rothblatt's recent trades

  • Martine A. Rothblatt

    Planned sale10b5-1 planUnited Therapeutics

    $113.3M

    Filed 10/01

  • Martine A. Rothblatt

    Sell10b5-1 planUnited Therapeutics

    $1.1M

    Filed 09/30

  • Martine A. Rothblatt

    Sell10b5-1 planUnited Therapeutics

    $1M

    Filed 09/30

  • Martine A. Rothblatt

    Sell10b5-1 planUnited Therapeutics

    $664.2K

    Filed 09/30

  • Martine A. Rothblatt

    Sell10b5-1 planUnited Therapeutics

    $574.9K

    Filed 09/30

Martine A. Rothblatt, Chairman — sold $1.3M of United Therapeutics UTHR · 5.0% of holdings · 10b5-1 plan | Whalegun